search
Back to results

A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens

Primary Purpose

Presbyopia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
LD127025 MF
Air Optix Aqua MF
Sponsored by
Bausch & Lomb Incorporated
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Presbyopia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  • Have physiologically normal anterior segments not exhibiting biomicroscopy findings Grade 2 or greater and/or presence of infiltrates.
  • Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Be correctable through spherocylindrical refraction to 42 letters (0.1 logMAR) or better (distance, high contrast) in each eye.
  • Require contact lens correction from -5.00 D to +3.00 D in each eye.
  • Be Presbyopic and require near add correction from +1.00 D to +1.75 D in each eye.
  • Be an adapted monovision soft contact lens wearer or multifocal soft contact lens wearer or an adapted spherical soft contact lens wearer who also uses spectacles for near vision correction.
  • Be willing to use a lens care system as required by the lens replacement schedule.
  • Has a distance spherical equivalent refraction between -5.50 D and +3.00 D.

Exclusion Criteria:

  • Not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact lenses.
  • Participated in any drug or device clinical investigation (within 14 days) prior to entry into this study and/or during the period of study participation.
  • Women of childbearing potential if one of the following: pregnant, plans to become pregnant during study, is breast-feeding.
  • Any Grade 2 or greater finding during the slit lamp examination. Subjects with corneal infiltrates of ANY GRADE are not eligible.
  • Any scar or neovascularization within the central 4mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
  • Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
  • Anisometropia (spherical equivalent) of greater than 2.00 D.
  • Aphakic.
  • Amblyopic.
  • Allergic to any component in the study care products.
  • Meet any of the following criteria:
  • Ophthalmologist, OD, Optician, Ophthalmologist's Assistant/Technician
  • employee of a market research firm
  • employee of manufacturer of contact lens or contact lens care products
  • Ocular astigmatism of greater than 1.00 D in either eye.
  • Have had any corneal surgery (ie, refractive surgery).
  • Toric contact lens wearer.
  • Have worn gas permeable (GP) contact lenses within the last 30 days or PMMA lenses within the last 3 months.
  • Have an active ocular disease or are using any ocular medication.
  • Have any systemic disease currently affecting ocular health or which, in the Investigator's opinion, may have an effect on ocular health during the course of the study.
  • Using any systemic medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.

Sites / Locations

  • Bausch & Lomb Incorporated

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

LD127025 MF

Air Optix Aqua MF

Arm Description

Mid add daily disposable soft contact lens worn on a daily wear basis for 1 week.

Medium add daily disposable soft contact lens worn on a daily wear basis for one week.

Outcomes

Primary Outcome Measures

Mean Visual Acuity
Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Secondary Outcome Measures

Symptoms/Complaints
Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.

Full Information

First Posted
October 8, 2013
Last Updated
September 9, 2020
Sponsor
Bausch & Lomb Incorporated
search

1. Study Identification

Unique Protocol Identification Number
NCT01959178
Brief Title
A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens
Official Title
A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
August 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bausch & Lomb Incorporated

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is to evaluate the product performance of the investigational LD127025 MF mid add soft contact lens compared to CIBA Vision's Air Optix Aqua MF MED add soft contact lenses when used among currently adapted soft contact lens wearers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Presbyopia

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
146 (Actual)

8. Arms, Groups, and Interventions

Arm Title
LD127025 MF
Arm Type
Experimental
Arm Description
Mid add daily disposable soft contact lens worn on a daily wear basis for 1 week.
Arm Title
Air Optix Aqua MF
Arm Type
Active Comparator
Arm Description
Medium add daily disposable soft contact lens worn on a daily wear basis for one week.
Intervention Type
Device
Intervention Name(s)
LD127025 MF
Intervention Description
At Visit 1, one-half of the subjects will be randomized to receive the investigational soft contact lens, after approximately one week of wearing the first lens type, the subjects will return for the 1-Week Crossover Visit (Visit 2) for an exam, and to determine if the subject remains eligible to continue in the next phase of the study with the control soft contact lens.
Intervention Type
Device
Intervention Name(s)
Air Optix Aqua MF
Intervention Description
At Visit 1, one-half of the subjects will be randomized to receive the control soft contact lens, after approximately one week of wearing the first lens type, the subjects will return for the 1-Week Crossover Visit (Visit 2) for an exam, and to determine if the subject remains eligible to continue in the next phase of the study with the investigational soft contact lens.
Primary Outcome Measure Information:
Title
Mean Visual Acuity
Description
Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).
Time Frame
At 1 Week follow up
Secondary Outcome Measure Information:
Title
Symptoms/Complaints
Description
Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.
Time Frame
At 1 Week follow up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Have physiologically normal anterior segments not exhibiting biomicroscopy findings Grade 2 or greater and/or presence of infiltrates. Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand. Be correctable through spherocylindrical refraction to 42 letters (0.1 logMAR) or better (distance, high contrast) in each eye. Require contact lens correction from -5.00 D to +3.00 D in each eye. Be Presbyopic and require near add correction from +1.00 D to +1.75 D in each eye. Be an adapted monovision soft contact lens wearer or multifocal soft contact lens wearer or an adapted spherical soft contact lens wearer who also uses spectacles for near vision correction. Be willing to use a lens care system as required by the lens replacement schedule. Has a distance spherical equivalent refraction between -5.50 D and +3.00 D. Exclusion Criteria: Not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact lenses. Participated in any drug or device clinical investigation (within 14 days) prior to entry into this study and/or during the period of study participation. Women of childbearing potential if one of the following: pregnant, plans to become pregnant during study, is breast-feeding. Any Grade 2 or greater finding during the slit lamp examination. Subjects with corneal infiltrates of ANY GRADE are not eligible. Any scar or neovascularization within the central 4mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study. Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear. Anisometropia (spherical equivalent) of greater than 2.00 D. Aphakic. Amblyopic. Allergic to any component in the study care products. Meet any of the following criteria: Ophthalmologist, OD, Optician, Ophthalmologist's Assistant/Technician employee of a market research firm employee of manufacturer of contact lens or contact lens care products Ocular astigmatism of greater than 1.00 D in either eye. Have had any corneal surgery (ie, refractive surgery). Toric contact lens wearer. Have worn gas permeable (GP) contact lenses within the last 30 days or PMMA lenses within the last 3 months. Have an active ocular disease or are using any ocular medication. Have any systemic disease currently affecting ocular health or which, in the Investigator's opinion, may have an effect on ocular health during the course of the study. Using any systemic medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Stefffen
Organizational Affiliation
Bausch & Lomb Incorporated
Official's Role
Study Director
Facility Information:
Facility Name
Bausch & Lomb Incorporated
City
Rochester
State/Province
New York
ZIP/Postal Code
14609
Country
United States

12. IPD Sharing Statement

Learn more about this trial

A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens

We'll reach out to this number within 24 hrs